Inhibiting the expression of anti-apoptotic genes BCL2L1 and MCL1, and apoptosis induction in glioblastoma cells by microRNA-342
Glioma is an aggressive and lethal type of brain tumor that originates from glial cells. Glioblastoma cells confer considerable resistance to induction of apoptosis, which may be due to overexpression of anti-apoptotic proteins, or the reduction of the level of some pro-apoptotic proteins. MicroRNAs...
Main Authors: | Shokoofeh Ghaemi, Ehsan Arefian, Rezvan Rezazadeh Valojerdi, Masoud Soleimani, Atieh Moradimotlagh, Fatemeh Jamshidi Adegani |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332219352631 |
Similar Items
-
MCL1 inhibition is effective against a subset of small-cell lung cancer with high MCL1 and low BCL-XL expression
by: Yasuda, Yuto
Published: (2020) -
The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition
by: Peddaboina Chander, et al.
Published: (2012-11-01) -
Potential mechanisms of resistance to venetoclax and strategies to circumvent it
by: Stephen K. Tahir, et al.
Published: (2017-06-01) -
Conception, synthèse et évaluation biologique d’inhibiteurs des protéines anti-apoptotiques de la famille Bcl-2
by: Abou samra, Alma
Published: (2017) -
Combination strategies to overcome resistance to the BCL2 inhibitor venetoclax in hematologic malignancies
by: XiaoYan Yue, et al.
Published: (2020-10-01)